Rogelio Hernández-Pando Selected Research

Colitis-Associated Neoplasms

1/2020	Corrigendum to "Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer".
1/2019	Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer.
7/2016	Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rogelio Hernández-Pando Research Topics

Disease

39	Tuberculosis (Tuberculoses) 06/2022 - 01/2005
35	Infections 08/2021 - 08/2002
24	Pulmonary Tuberculosis 02/2022 - 01/2005
11	Inflammation (Inflammations) 01/2022 - 01/2003
11	Neoplasms (Cancer) 08/2021 - 01/2006
8	Pneumonia (Pneumonitis) 11/2021 - 03/2006
8	Proteinuria 05/2018 - 09/2002
6	Fibrosis (Cirrhosis) 08/2021 - 10/2011
6	Acute Kidney Injury (Acute Renal Failure) 11/2020 - 07/2003
6	Granuloma 03/2019 - 06/2004
5	Body Weight (Weight, Body) 01/2021 - 04/2004
5	Mitochondrial Diseases (Mitochondrial Disease) 02/2016 - 08/2011
5	Necrosis 01/2013 - 08/2003
4	Ischemia 01/2022 - 11/2005
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2021 - 09/2013
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 01/2006
4	Chronic Renal Insufficiency 04/2021 - 03/2017
4	Hypoxia (Hypoxemia) 11/2018 - 01/2008
3	Lung Diseases (Lung Disease) 08/2021 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2005
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2004
3	Persistent Infection 01/2020 - 09/2012
3	Colitis-Associated Neoplasms 01/2020 - 07/2016
3	Asthma (Bronchial Asthma) 01/2019 - 04/2010
3	Communicable Diseases (Infectious Diseases) 12/2017 - 01/2006
3	Latent Tuberculosis 10/2016 - 01/2010
3	Latent Infection 01/2013 - 05/2007
3	Hypersensitivity (Allergy) 11/2008 - 08/2004
2	Neuroinflammatory Diseases 02/2022 - 06/2021
2	Carcinogenesis 08/2021 - 01/2014
2	Hyperinsulinism (Hyperinsulinemia) 01/2021 - 07/2007
2	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 09/2017 - 03/2017
2	Infarction (Infarctions) 01/2017 - 10/2015
2	Reperfusion Injury 01/2017 - 10/2015
2	Alcoholic Fatty Liver 01/2016 - 04/2015

Drug/Important Bio-Agent (IBA)

27	CytokinesIBA 11/2021 - 09/2002
22	Proteins (Proteins, Gene)FDA Link 08/2021 - 08/2003
16	VaccinesIBA 05/2022 - 01/2005
12	AntigensIBA 01/2021 - 08/2004
11	CreatinineIBA 01/2013 - 09/2002
10	CurcuminIBA 02/2022 - 10/2011
10	LipidsIBA 01/2021 - 09/2002
9	Pharmaceutical PreparationsIBA 12/2021 - 12/2006
8	Glutathione PeroxidaseIBA 05/2018 - 08/2003
8	Urea (Carbamide)FDA LinkGeneric 01/2013 - 08/2003
8	NitrogenIBA 01/2013 - 08/2003
7	AntioxidantsIBA 01/2022 - 07/2003
7	Antimicrobial PeptidesIBA 11/2021 - 01/2006
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 01/2004
6	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2006
6	EnzymesIBA 02/2013 - 07/2003
5	Adenosine Triphosphate (ATP)IBA 11/2020 - 10/2011
5	Messenger RNA (mRNA)IBA 10/2016 - 01/2004
5	Acetylglucosaminidase (NAGase)IBA 09/2004 - 08/2003
4	Interleukin-12 (IL 12)IBA 02/2022 - 01/2004
4	Therapeutic UsesIBA 06/2021 - 06/2008
4	CholesterolIBA 01/2021 - 03/2004
4	BCG Vaccine FDA Link 10/2019 - 01/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2004
4	AntibodiesIBA 01/2018 - 02/2004
4	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 09/2004
4	Monoclonal AntibodiesIBA 08/2009 - 08/2002
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2008 - 11/2007
4	Soybean Proteins (Soy Protein)IBA 07/2007 - 09/2002
3	CarbohydratesIBA 01/2022 - 07/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2006
3	titanium dioxide (Titania)FDA Link 12/2020 - 07/2015
3	Potassium Dichromate FDA Link 11/2020 - 09/2015
3	Biological ProductsIBA 01/2019 - 01/2010
3	Hexosaminidases (Hexosaminidase)IBA 05/2018 - 01/2012
3	Liposomes (Liposome)IBA 06/2015 - 02/2004
3	Triglycerides (Triacylglycerol)IBA 04/2015 - 09/2002
3	Isoniazid (Ftivazide)FDA LinkGeneric 01/2015 - 12/2006
3	DefensinsIBA 01/2015 - 01/2012
3	Oxidants (Oxidizing Agents)IBA 07/2013 - 08/2011
3	Interferon-gamma (Interferon, gamma)IBA 06/2008 - 01/2006
3	3-nitrotyrosineIBA 11/2007 - 04/2004
3	Gentamicins (Gentamicin)FDA LinkGeneric 04/2004 - 07/2003
3	Caseins (Casein)FDA Link 03/2004 - 09/2002
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2016
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2022 - 12/2020
2	CorticosteroneIBA 01/2021 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	LeptinIBA 01/2021 - 01/2021
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2020 - 01/2018
2	Macrophage Migration-Inhibitory FactorsIBA 01/2020 - 01/2019
2	Interleukin-1 (Interleukin 1)IBA 01/2020 - 07/2006
2	Mitogen-Activated Protein Kinase 3IBA 01/2020 - 01/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 01/2019
2	AcidsIBA 01/2019 - 10/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2018 - 02/2013
2	maleic acid (maleate)IBA 05/2018 - 11/2016
2	Interleukin-4 (Interleukin 4)IBA 01/2018 - 11/2008
2	sulforaphaneIBA 02/2017 - 08/2011
2	Oxidoreductases (Dehydrogenase)IBA 01/2017 - 01/2016
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 08/2015

Therapy/Procedure

4	Nephrectomy 04/2021 - 11/2005
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2005
2	Immunotherapy 01/2018 - 01/2006
2	Therapeutics 01/2016 - 09/2013